“A comparative study on the efficiency of patoladi ghrita pana and punarnavadhi anjana in Timira”
Background: Senile cataract is an age related vision threatening disease. It affects 12 to 15 million persons worldwide. In India approximately 3.38 million persons become blind from cataract every year. Senile immature cataract closely resembles the symptoms of Timira involving Prathama and Dwithiya patala. At present there is no time tested and proven medical treatment to delay, prevent or reverse the development of senile cataract. The present research work is aimed to evaluate easy, cost effective and prevent the deterioration of sight. Aims: To evaluate the efficacy of Patoladi ghrita pana and Punarnavadi anjana in the management of Timira. Research Design: Comparative clinical study Methods and Material: A total of 40 patients who are fulfilling the diagnostic and inclusion criteria were selected randomly and allotted in to 20 patients in each group. Group ‘A’ patients were treated with Patoladi gritha internally and Group ‘B’ patients were treated with Punarnavadi Anjana external application. Statistical analysis used: The data were graded based on standard methods and analyzed statistically using Paired ’t’ and Unpaired ’t’ tests. Results: Both the groups have shown statistically significant results. Group B patients showed better response when compared to group A. Conclusion: Both medicines were found to be effective in reducing the severity of the symptoms but were not sufficient enough to improve the visual acuity to higher extent and density of opacity. Patients with immature cataract with short duration showed better response when compared to that of longer duration.
Key Words: Timira, Patoladi ghrita, Punarnavadi Anjana, Senile cataract.
G.V.S.Murthy. Current status of cataract blindness and vision 2020: The right to sight initiation in India. 2008 Nov-Dec[Cited 29]; 56(6). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/pmc2612994/
Khurana. A.K. Comprehensive Ophthalmology; 4th edition, New Delhi: The Health Sciences Publisher; 2015;188
Yadavaji Trikamaji(editor). Commentary: Nibandhasangraha of Shri Dalhana on Sushruta Samhita of Sushruta, Uttaratantra, Chapter 7, verse no. 6,8th edition, Varanasi: Chaukhambha Orientalia; 2005;606
Yadavaji Trikamaji(editor). Commentary: Nibandhasangraha of Shri Dalhana on Sushruta Samhita of Sushruta, Uttaratantra, Chapter 7, verse no.10, 8th edition, Varanasi: Chaukhambha Orientalia; 2005;606
Khurana. A.K. Comprehensive Ophthalmology; 4th edition, New Delhi: The Health Sciences Publisher; 2015;191
Brahmanand Tripathi(editor). Astanga Hridaya of Vagbhata, Uttaratantra, Chapter 13, Verse no 6. 1st edition, Delhi: Chaukhamba Sanskrit Pratishthana; 2007:965.
Indradev Tripathi(editor). Commentary: Vaidyaprabha Hindi Commentary on Yogarathnakara of Yogarathnakara, Netraroga Chikitsa, Verse no 194. 1st edition, Varanasi: Chowkhamba Krishnadas Academy; 2004. 984
H.V. Nema. Diagnostic procedures in Ophthalmology; 2nd edition, New Delhi: Jaypee Brothers Medical Publishers Pvt. Ltd;2009.33.
Yadavaji Trikamaji(editor). Commentary: Nibandhasangraha of Shri Dalhana on Sushruta Samhita of Sushruta, Uttaratantra, Chapter 18, verse no.75, 8th edition, Varanasi: Chaukhambha Orientalia; 2005;638.
Kanski.S.Jack. Clinical Ophthalmology. 4th ed. Oxford: Buffer worth Heinemann International Publication; 2000. 514
van der Pols. JC. A possible role for vitamin C in age-related cataract. 1999 May; 58(2) Available from: https://www.ncbi.nlm.nih.gov/pubmed/10466170
Zhang Y. Vitamin E and risk of age-related cataract: a meta-analysis. 2015 Oct; 18(15) Available from: https://www.ncbi.nlm.nih.gov/pubmed/25591715.
Skalka.H.W. Cataracts and riboflavin deficiency. 1981 May; 34(5) Available from: https://www.ncbi.nlm.nih.gov/pubmed/7234715.
William.G.Christen. A prospective study of dietary carotenoids, vitamins C and E, and risk of cataract in women. 2008 Jan[Cited 24]; 126(1) Available from:
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution 3.0 License.